SS
RBOT

Steve Schonfeld’s Vicarious Surgical RBOT Stock Holding History

Steve Schonfeld’s Portfolio RBOT Stock Details RBOT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-596
Closed -$178K – 2240
2021
Q1 		$178K Sell
596
-591
-50% -$181K ﹤0.01% 1546
2020
Q4 		$362K Buy
1,187
+287
+32% +$84.3K ﹤0.01% 1141
2020
Q3 		$264K Buy
+900
New +$264K 0.01% 1132

Other funds holding RBOT

PAMP
Polar Asset Management Partners Toronto, Ontario, Canada $6.07B AUM 34.81% 1-Year Est. Return
AC
Athanor Capital New York $24.6M AUM 2.49% 1-Year Est. Return
SC
Sculptor Capital New York $12.3B AUM 40.26% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
Capstone Investment Advisors
Capstone Investment Advisors New York $54B AUM 23.5% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
PC
Periscope Capital Toronto, Ontario, Canada $1.14B AUM 6.91% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
TAL
TIG Advisors LLC New York $2.26B AUM 81.38% 1-Year Est. Return
SCM
Segantii Capital Management Hong Kong $1.54B AUM 16.73% 1-Year Est. Return

Steve Schonfeld's RBOT Position: Q2 2021 in Review

Steve Schonfeld sold out of Vicarious Surgical (RBOT) in Q2 2021, closing a stake of 596 shares — an estimated $178K sold.

Steve Schonfeld first reported a position in RBOT in Q3 2020 and held it in 3 quarters. The position peaked at $362K in Q4 2020. 98 funds tracked by Wall St. Rank hold RBOT as of Q2 2021.

  • Steve Schonfeld reported no remaining Vicarious Surgical position as of Q2 2021 after selling out during the quarter.
  • Steve Schonfeld sold 596 Vicarious Surgical shares in Q2 2021, an estimated $178K.
  • Steve Schonfeld first reported a position in Vicarious Surgical in Q3 2020 and held it in 3 quarters.
  • Steve Schonfeld's Vicarious Surgical position peaked at $362K in Q4 2020.
  • 98 funds tracked by Wall St. Rank held Vicarious Surgical as of Q2 2021.

Based on Schonfeld Strategic Advisors's 13F filing for Q2 2021, filed 16 Aug 2021.